Gordon Phillips
Concepts (541)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Bone Marrow Transplantation | 97 | 1979 | 90 |
Why?
| Hematopoietic Stem Cell Transplantation | 32 | 1990 | 49 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 50 | 1985 | 121 |
Why?
| Hodgkin Disease | 26 | 1986 | 46 |
Why?
| Graft vs Host Disease | 35 | 1986 | 29 |
Why?
| Lymphoma, Non-Hodgkin | 16 | 1990 | 41 |
Why?
| Amifostine | 5 | 2002 | 15 |
Why?
| Leukemia, Myeloid, Acute | 21 | 1980 | 53 |
Why?
| Transplantation, Autologous | 45 | 1982 | 78 |
Why?
| Lymphoma | 16 | 1980 | 96 |
Why?
| Leukemia | 30 | 1980 | 70 |
Why?
| Melphalan | 11 | 1983 | 24 |
Why?
| Cytarabine | 25 | 1980 | 32 |
Why?
| Transplantation, Homologous | 31 | 1986 | 94 |
Why?
| Adult | 116 | 1971 | 1317 |
Why?
| Cyclophosphamide | 24 | 1984 | 82 |
Why?
| Combined Modality Therapy | 36 | 1983 | 219 |
Why?
| Middle Aged | 98 | 1971 | 1161 |
Why?
| Humans | 175 | 1971 | 1856 |
Why?
| Carmustine | 14 | 1979 | 25 |
Why?
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 15 | 1989 | 26 |
Why?
| Cytoprotection | 3 | 2002 | 32 |
Why?
| Hematopoietic Stem Cells | 15 | 1989 | 69 |
Why?
| Etoposide | 17 | 1986 | 37 |
Why?
| Female | 104 | 1971 | 1643 |
Why?
| Methylprednisolone | 3 | 1988 | 41 |
Why?
| Cancer Vaccines | 3 | 2000 | 21 |
Why?
| Remission Induction | 18 | 1989 | 64 |
Why?
| Male | 99 | 1971 | 1553 |
Why?
| Radiation-Protective Agents | 3 | 2002 | 28 |
Why?
| Adolescent | 58 | 1971 | 891 |
Why?
| Myelodysplastic Syndromes | 7 | 1991 | 27 |
Why?
| Antibodies, Anti-Idiotypic | 3 | 2000 | 35 |
Why?
| Breast Neoplasms | 6 | 1983 | 185 |
Why?
| Transplantation Conditioning | 5 | 1999 | 23 |
Why?
| Aged | 44 | 1971 | 988 |
Why?
| Leukemia, Myeloid | 9 | 1989 | 37 |
Why?
| Gastrointestinal Tract | 1 | 2011 | 26 |
Why?
| Neoplasms | 7 | 1979 | 239 |
Why?
| Busulfan | 9 | 1984 | 9 |
Why?
| Treatment Outcome | 22 | 1993 | 661 |
Why?
| Peripheral Blood Stem Cell Transplantation | 3 | 2003 | 17 |
Why?
| Multiple Myeloma | 7 | 1990 | 44 |
Why?
| Disease-Free Survival | 18 | 1995 | 102 |
Why?
| Salvage Therapy | 10 | 1992 | 37 |
Why?
| Stem Cell Transplantation | 3 | 2003 | 50 |
Why?
| Glucocorticoids | 1 | 2011 | 107 |
Why?
| Maximum Tolerated Dose | 2 | 2004 | 18 |
Why?
| Neoplasm Recurrence, Local | 7 | 1985 | 118 |
Why?
| Liver | 4 | 1992 | 248 |
Why?
| Immunosuppressive Agents | 3 | 1995 | 102 |
Why?
| Survival Analysis | 17 | 1991 | 205 |
Why?
| Stem Cells | 2 | 2000 | 107 |
Why?
| T-Lymphocytes | 5 | 1990 | 182 |
Why?
| Interleukin-2 | 3 | 1991 | 71 |
Why?
| Tissue Donors | 6 | 1987 | 41 |
Why?
| Whole-Body Irradiation | 7 | 1984 | 43 |
Why?
| Methotrexate | 5 | 1986 | 40 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 6 | 1990 | 53 |
Why?
| Antineoplastic Agents | 8 | 1971 | 190 |
Why?
| Antibodies, Monoclonal | 8 | 1990 | 241 |
Why?
| Child | 29 | 1971 | 749 |
Why?
| Survival Rate | 17 | 1991 | 250 |
Why?
| Prognosis | 14 | 1980 | 388 |
Why?
| Antineoplastic Agents, Alkylating | 3 | 1996 | 30 |
Why?
| Bone Marrow | 14 | 1982 | 109 |
Why?
| Hematopoietic Stem Cell Mobilization | 2 | 1999 | 12 |
Why?
| Glycolipids | 2 | 2001 | 13 |
Why?
| Drug Toxicity | 1 | 2004 | 16 |
Why?
| Pancytopenia | 4 | 1985 | 13 |
Why?
| Retrospective Studies | 14 | 1991 | 653 |
Why?
| Follow-Up Studies | 14 | 1984 | 553 |
Why?
| Antigens, CD34 | 5 | 1997 | 26 |
Why?
| Melanoma | 5 | 1983 | 87 |
Why?
| Glycoproteins | 2 | 2001 | 113 |
Why?
| Recurrence | 14 | 1984 | 261 |
Why?
| Bone Marrow Purging | 4 | 1993 | 5 |
Why?
| Vulvar Neoplasms | 2 | 1990 | 12 |
Why?
| Time Factors | 18 | 1980 | 896 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 | 1991 | 33 |
Why?
| Acute Disease | 17 | 1981 | 271 |
Why?
| Dose-Response Relationship, Drug | 14 | 1981 | 431 |
Why?
| Hematopoiesis | 8 | 1984 | 47 |
Why?
| Leukemia, Promyelocytic, Acute | 2 | 1995 | 16 |
Why?
| Cyclosporine | 3 | 1991 | 45 |
Why?
| Anemia, Hemolytic | 2 | 1991 | 14 |
Why?
| Granulocyte Colony-Stimulating Factor | 2 | 1999 | 34 |
Why?
| Receptors, Interleukin-3 | 1 | 2000 | 3 |
Why?
| Neoplasms, Second Primary | 3 | 1993 | 31 |
Why?
| Incidence | 7 | 1991 | 336 |
Why?
| Plasmapheresis | 1 | 2000 | 20 |
Why?
| Leukemia, Erythroblastic, Acute | 1 | 2009 | 15 |
Why?
| Antigens, Neoplasm | 2 | 1997 | 56 |
Why?
| Immunoglobulin M | 2 | 1990 | 81 |
Why?
| Leukocyte Count | 9 | 1979 | 94 |
Why?
| Classification | 1 | 2009 | 13 |
Why?
| World Health Organization | 1 | 2009 | 19 |
Why?
| Tacrolimus | 1 | 2000 | 39 |
Why?
| Anemia, Aplastic | 3 | 1991 | 10 |
Why?
| Quality of Life | 2 | 1999 | 188 |
Why?
| Lymphocyte Activation | 3 | 1991 | 137 |
Why?
| Hemorrhage | 4 | 1983 | 103 |
Why?
| Platelet Transfusion | 4 | 1982 | 20 |
Why?
| Fever | 3 | 1991 | 65 |
Why?
| Immunotherapy | 3 | 1991 | 48 |
Why?
| Young Adult | 5 | 2009 | 380 |
Why?
| Immunotoxins | 2 | 1990 | 2 |
Why?
| Infant | 8 | 1971 | 464 |
Why?
| HLA Antigens | 7 | 1987 | 38 |
Why?
| Histocompatibility | 5 | 1987 | 15 |
Why?
| Child, Preschool | 14 | 1971 | 554 |
Why?
| Leukemia, Monocytic, Acute | 3 | 1980 | 10 |
Why?
| Recombinant Proteins | 4 | 1990 | 290 |
Why?
| Translocation, Genetic | 2 | 1993 | 35 |
Why?
| Paternity | 1 | 1996 | 2 |
Why?
| Drug Resistance | 6 | 1986 | 83 |
Why?
| Twins, Dizygotic | 1 | 1996 | 7 |
Why?
| Hepatic Veno-Occlusive Disease | 2 | 1992 | 3 |
Why?
| Neoplasms, Germ Cell and Embryonal | 2 | 1993 | 10 |
Why?
| Vancomycin | 2 | 1991 | 23 |
Why?
| Reticulocytes | 1 | 1996 | 23 |
Why?
| Rhabdomyolysis | 1 | 1995 | 9 |
Why?
| Cystitis | 2 | 1991 | 11 |
Why?
| Neutrophils | 7 | 1979 | 114 |
Why?
| Neutropenia | 3 | 1983 | 42 |
Why?
| Cyclosporins | 2 | 1988 | 11 |
Why?
| Herpesvirus 4, Human | 1 | 1995 | 34 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 3 | 1982 | 38 |
Why?
| Lymphoproliferative Disorders | 1 | 1995 | 23 |
Why?
| Mice, Inbred NOD | 3 | 2000 | 24 |
Why?
| Blast Crisis | 2 | 1992 | 12 |
Why?
| Vulva | 1 | 1994 | 13 |
Why?
| Leucovorin | 2 | 1992 | 11 |
Why?
| Postoperative Complications | 2 | 1988 | 305 |
Why?
| Immunologic Factors | 1 | 1995 | 46 |
Why?
| Daunorubicin | 7 | 1980 | 10 |
Why?
| Mice, SCID | 3 | 2000 | 61 |
Why?
| Teicoplanin | 2 | 1991 | 2 |
Why?
| Topoisomerase II Inhibitors | 1 | 1993 | 5 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 1993 | 10 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 1993 | 19 |
Why?
| Cerebellar Diseases | 2 | 1987 | 10 |
Why?
| Severity of Illness Index | 3 | 1997 | 358 |
Why?
| Vincristine | 7 | 1989 | 27 |
Why?
| Immunization, Passive | 2 | 1988 | 39 |
Why?
| Testicular Neoplasms | 1 | 1993 | 26 |
Why?
| Gram-Positive Bacterial Infections | 1 | 1993 | 16 |
Why?
| Hypersplenism | 1 | 1992 | 3 |
Why?
| Prospective Studies | 7 | 1992 | 545 |
Why?
| Interferon-alpha | 2 | 1991 | 43 |
Why?
| Doxorubicin | 9 | 1985 | 60 |
Why?
| Clinical Trials as Topic | 6 | 1985 | 251 |
Why?
| Mesna | 1 | 1991 | 2 |
Why?
| Drug Administration Schedule | 8 | 1981 | 191 |
Why?
| Leukocyte Transfusion | 3 | 1993 | 6 |
Why?
| Cisplatin | 5 | 1985 | 43 |
Why?
| Fluid Therapy | 1 | 1991 | 24 |
Why?
| Medical Records | 2 | 1971 | 104 |
Why?
| Injections, Intra-Arterial | 1 | 2011 | 28 |
Why?
| Graft Survival | 7 | 1990 | 74 |
Why?
| Cell Separation | 5 | 1981 | 110 |
Why?
| Immunologic Deficiency Syndromes | 2 | 1987 | 30 |
Why?
| Lymphocyte Subsets | 1 | 1991 | 26 |
Why?
| Canada | 4 | 1991 | 60 |
Why?
| Mucositis | 1 | 2010 | 12 |
Why?
| Graft Rejection | 3 | 1990 | 59 |
Why?
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 1998 | 28 |
Why?
| Stomatitis, Herpetic | 1 | 1990 | 7 |
Why?
| Blood Transfusion | 2 | 1982 | 59 |
Why?
| Immunophenotyping | 4 | 1993 | 66 |
Why?
| Seizures | 2 | 1989 | 79 |
Why?
| Dysgammaglobulinemia | 1 | 1990 | 1 |
Why?
| IgA Deficiency | 1 | 1990 | 3 |
Why?
| Colony-Stimulating Factors | 1 | 1990 | 13 |
Why?
| Brain Death | 1 | 1990 | 7 |
Why?
| Phenytoin | 1 | 1989 | 16 |
Why?
| Sinusitis | 1 | 1990 | 22 |
Why?
| Interleukin-4 | 1 | 1991 | 62 |
Why?
| Cytomegalovirus Infections | 2 | 1981 | 39 |
Why?
| Immunoglobulin A | 1 | 1990 | 39 |
Why?
| Death, Sudden | 1 | 1990 | 23 |
Why?
| Growth Substances | 1 | 1990 | 51 |
Why?
| Cell Survival | 4 | 1982 | 229 |
Why?
| Histocompatibility Testing | 3 | 1995 | 24 |
Why?
| Atrial Fibrillation | 1 | 2010 | 40 |
Why?
| Erythrocyte Transfusion | 2 | 2005 | 29 |
Why?
| ABO Blood-Group System | 2 | 2005 | 26 |
Why?
| Disease Progression | 2 | 2003 | 244 |
Why?
| Lymphocytes | 4 | 1990 | 142 |
Why?
| Intestinal Diseases | 1 | 1988 | 15 |
Why?
| Diabetes Mellitus | 1 | 2009 | 72 |
Why?
| Chromosome Aberrations | 4 | 1985 | 45 |
Why?
| Brain Neoplasms | 3 | 1983 | 116 |
Why?
| Pneumonia, Viral | 1 | 1988 | 17 |
Why?
| Blood Cells | 3 | 1985 | 19 |
Why?
| Pyrimidines | 1 | 2008 | 49 |
Why?
| Piperazines | 1 | 2008 | 57 |
Why?
| Risk Factors | 7 | 1991 | 555 |
Why?
| Philadelphia Chromosome | 2 | 1986 | 11 |
Why?
| Heterocyclic Compounds | 1 | 2007 | 11 |
Why?
| Actuarial Analysis | 3 | 1991 | 21 |
Why?
| Blood Cell Count | 3 | 1984 | 31 |
Why?
| Comorbidity | 1 | 2009 | 190 |
Why?
| Health Status | 1 | 2009 | 127 |
Why?
| Aged, 80 and over | 4 | 1993 | 599 |
Why?
| Antigens, CD | 2 | 1995 | 128 |
Why?
| Prednisone | 5 | 1989 | 80 |
Why?
| Chronic Disease | 5 | 1984 | 267 |
Why?
| Leukemia, Lymphoid | 1 | 1986 | 22 |
Why?
| Carcinoma, Adenoid Cystic | 1 | 1985 | 7 |
Why?
| Analysis of Variance | 5 | 1991 | 339 |
Why?
| Cells, Cultured | 9 | 1989 | 447 |
Why?
| Animals | 9 | 1991 | 1031 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2005 | 61 |
Why?
| Thioguanine | 2 | 1980 | 5 |
Why?
| Cohort Studies | 3 | 1997 | 332 |
Why?
| Cell Communication | 1 | 2005 | 72 |
Why?
| British Columbia | 4 | 1991 | 2 |
Why?
| Glioma | 1 | 1986 | 51 |
Why?
| Uterine Cervical Neoplasms | 1 | 1985 | 55 |
Why?
| Cell Movement | 1 | 2007 | 163 |
Why?
| Cell Count | 3 | 1992 | 163 |
Why?
| Treatment Failure | 1 | 2004 | 88 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 1992 | 210 |
Why?
| Cytotoxicity, Immunologic | 2 | 1994 | 54 |
Why?
| Infusions, Intravenous | 2 | 1994 | 87 |
Why?
| Carboplatin | 2 | 1993 | 16 |
Why?
| Drug Therapy, Combination | 4 | 1980 | 189 |
Why?
| Mice | 4 | 1992 | 623 |
Why?
| Drug Evaluation | 3 | 1983 | 54 |
Why?
| Hematologic Neoplasms | 1 | 2003 | 19 |
Why?
| Multicenter Studies as Topic | 2 | 1993 | 70 |
Why?
| Injections, Intradermal | 1 | 2003 | 15 |
Why?
| Mitoxantrone | 2 | 1993 | 9 |
Why?
| Apoptosis | 3 | 2001 | 265 |
Why?
| Tobramycin | 2 | 1991 | 7 |
Why?
| Endothelial Cells | 1 | 2005 | 80 |
Why?
| Procarbazine | 4 | 1989 | 6 |
Why?
| Mechlorethamine | 4 | 1989 | 7 |
Why?
| Sepsis | 2 | 1993 | 73 |
Why?
| Vinblastine | 4 | 1989 | 22 |
Why?
| Life Tables | 3 | 1993 | 33 |
Why?
| Bleomycin | 4 | 1989 | 28 |
Why?
| Neoplasm Metastasis | 1 | 2003 | 112 |
Why?
| Dexamethasone | 3 | 1993 | 109 |
Why?
| Bone Marrow Diseases | 3 | 1983 | 31 |
Why?
| Pilot Projects | 3 | 1991 | 264 |
Why?
| Plateletpheresis | 1 | 1981 | 5 |
Why?
| Platelet Count | 4 | 1979 | 39 |
Why?
| Gene Expression Regulation, Leukemic | 1 | 2001 | 16 |
Why?
| Bone Marrow Cells | 3 | 1989 | 92 |
Why?
| Genes, Tumor Suppressor | 1 | 2001 | 37 |
Why?
| Morbidity | 1 | 2000 | 62 |
Why?
| Immunity, Cellular | 1 | 2001 | 85 |
Why?
| Age Factors | 4 | 1987 | 480 |
Why?
| Cause of Death | 4 | 1993 | 82 |
Why?
| Dacarbazine | 3 | 1989 | 18 |
Why?
| Nervous System Diseases | 1 | 1991 | 78 |
Why?
| Kidney Diseases | 2 | 1991 | 90 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2001 | 38 |
Why?
| Killer Cells, Natural | 3 | 1994 | 62 |
Why?
| Monitoring, Physiologic | 1 | 1990 | 81 |
Why?
| Myeloproliferative Disorders | 1 | 1999 | 7 |
Why?
| Blood Donors | 1 | 1999 | 19 |
Why?
| Lymphatic Metastasis | 1 | 2000 | 77 |
Why?
| Phosphoproteins | 1 | 2001 | 86 |
Why?
| Lung Diseases | 3 | 1983 | 112 |
Why?
| Liver Neoplasms | 1 | 2000 | 97 |
Why?
| Blood Platelets | 2 | 1981 | 67 |
Why?
| Monocytes | 2 | 1990 | 124 |
Why?
| Adenoviridae | 1 | 1999 | 60 |
Why?
| Interviews as Topic | 1 | 1999 | 94 |
Why?
| Bone Neoplasms | 1 | 2000 | 83 |
Why?
| Neoplasm Proteins | 1 | 2001 | 110 |
Why?
| Tumor Cells, Cultured | 4 | 1990 | 233 |
Why?
| Polymorphism, Genetic | 1 | 2009 | 94 |
Why?
| Gene Transfer Techniques | 1 | 1999 | 59 |
Why?
| Socioeconomic Factors | 1 | 1999 | 144 |
Why?
| Macrophage Inflammatory Proteins | 1 | 1997 | 17 |
Why?
| Intensive Care | 1 | 1998 | 33 |
Why?
| Growth Inhibitors | 1 | 1997 | 33 |
Why?
| Neoplastic Stem Cells | 2 | 1993 | 21 |
Why?
| Regression Analysis | 3 | 1991 | 256 |
Why?
| Neoplasm Staging | 3 | 1990 | 125 |
Why?
| Methods | 2 | 1971 | 133 |
Why?
| HLA-DR Antigens | 1 | 1996 | 37 |
Why?
| Blood Grouping and Crossmatching | 2 | 2005 | 14 |
Why?
| Astrocytoma | 2 | 1986 | 26 |
Why?
| Antibodies, Viral | 2 | 1988 | 104 |
Why?
| Coculture Techniques | 2 | 2005 | 59 |
Why?
| Reticulocyte Count | 1 | 1996 | 3 |
Why?
| Lymphocytosis | 1 | 1995 | 9 |
Why?
| Blotting, Northern | 2 | 1992 | 151 |
Why?
| Glioblastoma | 2 | 1986 | 44 |
Why?
| Graft vs Host Reaction | 2 | 1981 | 4 |
Why?
| DNA-Binding Proteins | 1 | 2001 | 204 |
Why?
| Leukapheresis | 2 | 1990 | 17 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 2 | 2002 | 33 |
Why?
| Antibody Formation | 2 | 1990 | 89 |
Why?
| Neuroblastoma | 2 | 1983 | 36 |
Why?
| Antigens, CD5 | 1 | 1995 | 11 |
Why?
| Immunotherapy, Adoptive | 1 | 1995 | 10 |
Why?
| Leukemia, Experimental | 1 | 1995 | 20 |
Why?
| Neoplasm, Residual | 1 | 1995 | 19 |
Why?
| Colony-Forming Units Assay | 2 | 1991 | 27 |
Why?
| Transplantation Immunology | 1 | 1995 | 19 |
Why?
| Digestive System Diseases | 1 | 1994 | 4 |
Why?
| Adrenal Cortex Hormones | 2 | 1990 | 76 |
Why?
| Podophyllotoxin | 1 | 1994 | 7 |
Why?
| Lung Diseases, Obstructive | 1 | 1994 | 30 |
Why?
| Probability | 2 | 1986 | 190 |
Why?
| Questionnaires | 1 | 1999 | 360 |
Why?
| Clinical Trials, Phase I as Topic | 1 | 1994 | 13 |
Why?
| Lung Diseases, Interstitial | 1 | 1994 | 11 |
Why?
| Polymerase Chain Reaction | 1 | 1996 | 279 |
Why?
| Skin Neoplasms | 2 | 1982 | 97 |
Why?
| Ifosfamide | 1 | 1993 | 2 |
Why?
| Feasibility Studies | 1 | 1994 | 144 |
Why?
| Infection | 1 | 1994 | 57 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 1993 | 14 |
Why?
| Chromosomes, Human, Pair 18 | 1 | 1993 | 14 |
Why?
| Karyotyping | 3 | 1984 | 47 |
Why?
| Cell Line | 2 | 1994 | 375 |
Why?
| Superinfection | 1 | 1993 | 1 |
Why?
| Leukemia, Myelomonocytic, Acute | 1 | 1993 | 6 |
Why?
| Heart Diseases | 1 | 1994 | 92 |
Why?
| Chromatography, Gas | 1 | 1993 | 21 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 1993 | 13 |
Why?
| Double-Blind Method | 2 | 1991 | 274 |
Why?
| Receptors, Interleukin-2 | 1 | 1992 | 31 |
Why?
| Survivors | 1 | 1994 | 45 |
Why?
| Splenectomy | 1 | 1992 | 29 |
Why?
| Clinical Protocols | 1 | 1993 | 93 |
Why?
| Liver Circulation | 1 | 1992 | 14 |
Why?
| Gallbladder | 1 | 1992 | 18 |
Why?
| Lymphoma, B-Cell | 1 | 1993 | 33 |
Why?
| Immunocompromised Host | 1 | 1993 | 70 |
Why?
| Catheters, Indwelling | 1 | 1993 | 46 |
Why?
| Mouth Mucosa | 1 | 1992 | 28 |
Why?
| Piperacillin | 1 | 1991 | 6 |
Why?
| Catheterization, Central Venous | 1 | 1993 | 46 |
Why?
| Penicillins | 1 | 1993 | 35 |
Why?
| Culture Techniques | 1 | 1992 | 61 |
Why?
| Blood Flow Velocity | 1 | 1992 | 72 |
Why?
| Hematopoietic Cell Growth Factors | 1 | 1991 | 9 |
Why?
| Interferons | 1 | 1991 | 39 |
Why?
| Information Services | 1 | 1971 | 21 |
Why?
| Interleukins | 1 | 1991 | 32 |
Why?
| Mitogens | 1 | 1991 | 31 |
Why?
| Chromosomes, Human, Pair 22 | 1 | 1990 | 12 |
Why?
| Random Allocation | 1 | 1991 | 160 |
Why?
| Rats | 2 | 1995 | 530 |
Why?
| Ricin | 1 | 1990 | 3 |
Why?
| Prevalence | 1 | 1993 | 281 |
Why?
| Acyclovir | 1 | 1990 | 28 |
Why?
| Simplexvirus | 1 | 1990 | 33 |
Why?
| Antigens, CD8 | 1 | 1990 | 25 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 1 | 1990 | 23 |
Why?
| Blood Preservation | 2 | 1982 | 13 |
Why?
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1990 | 7 |
Why?
| Injections, Spinal | 1 | 1990 | 14 |
Why?
| Antigens, CD4 | 1 | 1990 | 29 |
Why?
| Leukoencephalopathy, Progressive Multifocal | 1 | 1990 | 10 |
Why?
| Consensus | 1 | 2009 | 12 |
Why?
| Cytokines | 1 | 1994 | 207 |
Why?
| Receptors, Antigen, T-Cell | 1 | 1990 | 34 |
Why?
| Lymphatic Irradiation | 1 | 1989 | 5 |
Why?
| Brain Edema | 1 | 1990 | 26 |
Why?
| Meningeal Neoplasms | 1 | 1990 | 30 |
Why?
| Diagnosis, Differential | 1 | 1992 | 402 |
Why?
| Cladribine | 1 | 2008 | 7 |
Why?
| Myeloablative Agonists | 1 | 2008 | 5 |
Why?
| Societies, Medical | 1 | 2009 | 90 |
Why?
| Randomized Controlled Trials as Topic | 2 | 1998 | 176 |
Why?
| United States | 2 | 1993 | 604 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2009 | 58 |
Why?
| Cell Division | 1 | 1991 | 273 |
Why?
| Reference Values | 1 | 2009 | 278 |
Why?
| Chromosomes, Human, 21-22 and Y | 2 | 1984 | 3 |
Why?
| Antigens, Human Platelet | 1 | 2007 | 7 |
Why?
| Cytomegalovirus | 1 | 1988 | 42 |
Why?
| Registries | 2 | 1998 | 83 |
Why?
| Leukocyte Reduction Procedures | 1 | 2007 | 8 |
Why?
| Blood Glucose | 1 | 2009 | 99 |
Why?
| Culture Media, Conditioned | 1 | 2007 | 45 |
Why?
| Chemokine CXCL12 | 1 | 2007 | 24 |
Why?
| Anti-Bacterial Agents | 1 | 1991 | 195 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2009 | 78 |
Why?
| Genetic Predisposition to Disease | 1 | 2009 | 131 |
Why?
| Virus Diseases | 1 | 1987 | 50 |
Why?
| Culture Media | 1 | 2007 | 116 |
Why?
| Escherichia coli | 1 | 1990 | 143 |
Why?
| Lomustine | 1 | 1986 | 4 |
Why?
| Alkylating Agents | 1 | 1986 | 15 |
Why?
| Gene Expression Regulation | 1 | 1992 | 277 |
Why?
| Proportional Hazards Models | 1 | 2007 | 123 |
Why?
| Abdominal Neoplasms | 1 | 1985 | 20 |
Why?
| Prednisolone | 1 | 1995 | 21 |
Why?
| Boronic Acids | 1 | 2005 | 16 |
Why?
| Cell Cycle | 1 | 2007 | 121 |
Why?
| Pyrazines | 1 | 2005 | 20 |
Why?
| Brain Diseases | 2 | 1981 | 75 |
Why?
| Pulmonary Fibrosis | 1 | 1986 | 48 |
Why?
| Risk | 1 | 1986 | 203 |
Why?
| Deoxycytidine | 1 | 2004 | 20 |
Why?
| Preservation, Biological | 1 | 1984 | 4 |
Why?
| Freezing | 1 | 1984 | 26 |
Why?
| Splenomegaly | 1 | 1984 | 14 |
Why?
| Cell Line, Tumor | 1 | 2007 | 208 |
Why?
| DNA | 1 | 1989 | 262 |
Why?
| Drug-Induced Liver Injury | 1 | 1983 | 16 |
Why?
| Phosphorylation | 1 | 2007 | 224 |
Why?
| Hematologic Diseases | 1 | 1983 | 23 |
Why?
| Bone Marrow Examination | 1 | 1983 | 11 |
Why?
| Tomography, X-Ray Computed | 2 | 1991 | 321 |
Why?
| Central Nervous System Diseases | 1 | 1983 | 33 |
Why?
| Cell Proliferation | 1 | 2007 | 227 |
Why?
| Tissue and Organ Procurement | 1 | 1993 | 16 |
Why?
| Polyenes | 1 | 1982 | 4 |
Why?
| Biopsy, Needle | 1 | 1983 | 94 |
Why?
| Mitomycins | 1 | 1982 | 13 |
Why?
| Hepatic Veins | 1 | 1982 | 10 |
Why?
| Odds Ratio | 1 | 2003 | 157 |
Why?
| Occipital Lobe | 1 | 1991 | 8 |
Why?
| Stomach Diseases | 1 | 1981 | 7 |
Why?
| Multivariate Analysis | 1 | 1994 | 225 |
Why?
| Data Collection | 1 | 1993 | 137 |
Why?
| Lung Neoplasms | 1 | 1985 | 159 |
Why?
| NAD+ Nucleosidase | 1 | 2001 | 6 |
Why?
| ADP-ribosyl Cyclase | 1 | 2001 | 6 |
Why?
| Interferon Regulatory Factor-1 | 1 | 2001 | 4 |
Why?
| Antigens, CD38 | 1 | 2001 | 7 |
Why?
| Immunosuppression | 1 | 1981 | 47 |
Why?
| Syndrome | 1 | 1991 | 142 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2001 | 20 |
Why?
| Patient Selection | 1 | 2003 | 155 |
Why?
| Antigens, Differentiation | 1 | 2001 | 53 |
Why?
| Vision Disorders | 1 | 1991 | 44 |
Why?
| Enzyme Induction | 1 | 2001 | 64 |
Why?
| Cobalt Radioisotopes | 1 | 1980 | 12 |
Why?
| Radiotherapy, High-Energy | 1 | 1980 | 16 |
Why?
| Hemostasis | 1 | 1981 | 44 |
Why?
| BCG Vaccine | 1 | 1980 | 22 |
Why?
| Reagent Kits, Diagnostic | 1 | 1990 | 16 |
Why?
| Radioimmunoassay | 1 | 1990 | 81 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1990 | 121 |
Why?
| Clone Cells | 2 | 1989 | 92 |
Why?
| Heart Transplantation | 1 | 1990 | 44 |
Why?
| Antigens, CD2 | 1 | 1998 | 4 |
Why?
| Delphi Technique | 1 | 1998 | 6 |
Why?
| Transduction, Genetic | 1 | 1999 | 65 |
Why?
| Nuclear Family | 1 | 1998 | 12 |
Why?
| Kidney Transplantation | 1 | 1990 | 66 |
Why?
| Steroids | 1 | 1998 | 38 |
Why?
| Chemokine CCL3 | 1 | 1997 | 9 |
Why?
| Chemokine CCL4 | 1 | 1997 | 16 |
Why?
| Hypertension | 1 | 1991 | 161 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 243 |
Why?
| Stomatitis | 1 | 1997 | 10 |
Why?
| Statistics as Topic | 2 | 1987 | 133 |
Why?
| Membrane Glycoproteins | 1 | 2001 | 154 |
Why?
| Lymphoma, Follicular | 1 | 1998 | 27 |
Why?
| HLA-DRB1 Chains | 1 | 1996 | 3 |
Why?
| Lymphocyte Culture Test, Mixed | 1 | 1996 | 21 |
Why?
| Intensive Care Units | 1 | 1998 | 53 |
Why?
| Haplotypes | 1 | 1996 | 28 |
Why?
| Homozygote | 1 | 1996 | 68 |
Why?
| Decision Making | 1 | 1998 | 130 |
Why?
| Fatal Outcome | 1 | 1996 | 86 |
Why?
| Pedigree | 1 | 1996 | 84 |
Why?
| Antigens, CD3 | 1 | 1995 | 37 |
Why?
| Brain | 1 | 1981 | 305 |
Why?
| Gene Rearrangement, B-Lymphocyte | 1 | 1993 | 13 |
Why?
| Blood Transfusion, Autologous | 1 | 1993 | 10 |
Why?
| Genes, myc | 1 | 1993 | 22 |
Why?
| DNA, Neoplasm | 1 | 1993 | 75 |
Why?
| Calibration | 1 | 1993 | 37 |
Why?
| Reference Standards | 1 | 1993 | 35 |
Why?
| Burkitt Lymphoma | 1 | 1993 | 36 |
Why?
| Cerebellar Ataxia | 2 | 1981 | 7 |
Why?
| Drug Monitoring | 1 | 1993 | 33 |
Why?
| Phenols | 1 | 1993 | 20 |
Why?
| Lung | 1 | 2000 | 232 |
Why?
| Sulfhydryl Compounds | 1 | 1993 | 42 |
Why?
| Methylcellulose | 1 | 1992 | 4 |
Why?
| Centrifugation, Density Gradient | 1 | 1992 | 48 |
Why?
| Thrombocytopenia | 2 | 1982 | 46 |
Why?
| Forecasting | 1 | 1993 | 147 |
Why?
| Glycopeptides | 1 | 1991 | 9 |
Why?
| Punched-Card Systems | 1 | 1971 | 2 |
Why?
| Medication Systems, Hospital | 1 | 1971 | 2 |
Why?
| Michigan | 1 | 1971 | 13 |
Why?
| Data Display | 1 | 1971 | 15 |
Why?
| Creatinine | 1 | 1991 | 69 |
Why?
| Computers | 1 | 1971 | 58 |
Why?
| Drug Interactions | 1 | 1991 | 111 |
Why?
| DNA Restriction Enzymes | 1 | 1990 | 44 |
Why?
| Gene Rearrangement | 1 | 1990 | 26 |
Why?
| Biopsy | 2 | 1981 | 207 |
Why?
| Lipopolysaccharides | 1 | 1992 | 98 |
Why?
| Granulocytes | 1 | 1990 | 46 |
Why?
| Kinetics | 1 | 1994 | 349 |
Why?
| Erythrocytes | 1 | 1992 | 109 |
Why?
| Continental Population Groups | 1 | 1971 | 85 |
Why?
| Interferon-gamma | 1 | 1992 | 133 |
Why?
| Macromolecular Substances | 1 | 1990 | 92 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1989 | 32 |
Why?
| Macrophages | 1 | 1992 | 148 |
Why?
| X Chromosome | 1 | 1989 | 24 |
Why?
| Cell Adhesion | 1 | 1990 | 113 |
Why?
| Sensitivity and Specificity | 1 | 1993 | 427 |
Why?
| Genotype | 1 | 1990 | 175 |
Why?
| Genetic Linkage | 1 | 1989 | 57 |
Why?
| Cell Differentiation | 1 | 1995 | 262 |
Why?
| Base Sequence | 1 | 1993 | 371 |
Why?
| Molecular Sequence Data | 1 | 1993 | 404 |
Why?
| Transcription, Genetic | 1 | 1992 | 253 |
Why?
| Infant, Newborn | 1 | 1971 | 389 |
Why?
| Anoxia | 1 | 1987 | 85 |
Why?
| Naphthacenes | 1 | 1985 | 3 |
Why?
| DNA Nucleotidylexotransferase | 1 | 1985 | 11 |
Why?
| Chromosome Disorders | 1 | 1985 | 17 |
Why?
| Infusions, Parenteral | 1 | 1985 | 38 |
Why?
| Life Expectancy | 1 | 1985 | 20 |
Why?
| Antibiotics, Antineoplastic | 1 | 1985 | 35 |
Why?
| RNA, Messenger | 1 | 1992 | 394 |
Why?
| Conjunctivitis | 1 | 1983 | 9 |
Why?
| Sarcoma, Ewing | 1 | 1983 | 8 |
Why?
| Gastrointestinal Diseases | 1 | 1983 | 31 |
Why?
| Drug Eruptions | 1 | 1983 | 26 |
Why?
| Evaluation Studies as Topic | 1 | 1983 | 178 |
Why?
| Diagnostic Errors | 1 | 1983 | 73 |
Why?
| Polyvinyl Chloride | 1 | 1982 | 1 |
Why?
| Drug Packaging | 1 | 1982 | 9 |
Why?
| Constriction, Pathologic | 1 | 1982 | 65 |
Why?
| Purkinje Cells | 1 | 1981 | 8 |
Why?
| Cognition Disorders | 1 | 1983 | 107 |
Why?
| Hydrogen-Ion Concentration | 1 | 1982 | 176 |
Why?
| Radiotherapy Dosage | 1 | 1980 | 55 |
Why?
| Skin | 1 | 1982 | 177 |
Why?
| Oxygen | 1 | 1982 | 179 |
Why?
|
|
Phillips's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
